ScoreWhy is Shaanxi Kanghui Pharmaceutical Co., Ltd. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 4.96% and Operating profit at -216.74% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
With a fall in Operating Profit of -47.94%, the company declared Very Negative results in Mar 25
- The company has declared negative results for the last 4 consecutive quarters
- NET PROFIT(HY) At CNY -66.43 MM has Grown at -93.7%
- ROCE(HY) Lowest at -12.06%
- DEBT-EQUITY RATIO (HY) Highest at 65.94 %
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 33.80%, its profits have fallen by -93.5%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shaanxi Kanghui Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Shaanxi Kanghui Pharmaceutical Co., Ltd.
-100.0%
1.57
47.17%
China Shanghai Composite
14.77%
1.01
14.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.96%
EBIT Growth (5y)
-216.74%
EBIT to Interest (avg)
2.31
Debt to EBITDA (avg)
18.68
Net Debt to Equity (avg)
0.66
Sales to Capital Employed (avg)
0.37
Tax Ratio
6.96%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.04%
ROE (avg)
1.20%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.44
EV to EBIT
-17.92
EV to EBITDA
-48.86
EV to Capital Employed
1.26
EV to Sales
3.21
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.06%
ROE (Latest)
-18.47%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
NET PROFIT(HY)
Higher at CNY -66.43 MM
-37What is not working for the Company
NET PROFIT(HY)
At CNY -66.43 MM has Grown at -93.7%
ROCE(HY)
Lowest at -12.06%
DEBT-EQUITY RATIO
(HY)
Highest at 65.94 %
OPERATING PROFIT(Q)
Lowest at CNY -20.94 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -17.8 %
RAW MATERIAL COST(Y)
Grown by 18.4% (YoY
CASH AND EQV(HY)
Lowest at CNY 203.24 MM
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.01%
NET SALES(Q)
Lowest at CNY 117.68 MM
INTEREST(Q)
Highest at CNY 10.86 MM
Here's what is working for Shaanxi Kanghui Pharmaceutical Co., Ltd.
Net Profit
Higher at CNY -66.43 MM
than preceding 12 month period ended Mar 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CNY MM)
Here's what is not working for Shaanxi Kanghui Pharmaceutical Co., Ltd.
Net Profit
At CNY -66.43 MM has Grown at -93.7%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Net Sales
At CNY 117.68 MM has Fallen at -14.31%
over average net sales of the previous four periods of CNY 137.34 MMMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Interest
At CNY 10.86 MM has Grown at 15.41%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Operating Profit
Lowest at CNY -20.94 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at -17.8 % and Fallen
In each period in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Debt-Equity Ratio
Highest at 65.94 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Net Sales
Lowest at CNY 117.68 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Interest
Highest at CNY 10.86 MM
in the last five periods and Increased by 15.41% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Cash and Eqv
Lowest at CNY 203.24 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio
Lowest at 2.01%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 18.4% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
